Joshua Goldstein

Joshua Goldstein possesses extensive experience in the biopharmaceutical industry, currently serving as CMC Leader at Aro Biotherapeutics since December 2021. Prior to this role, Joshua was Senior Program Manager at the Center for Breakthrough Medicines at Discovery Labs for nearly a year. Joshua's career at The Janssen Pharmaceutical Companies of Johnson & Johnson spanned over 17 years, during which time various positions included Associate Director, Senior Scientist, Scientist, Senior Associate Scientist, Associate Scientist I-II, and Assistant Scientist. Joshua holds a Bachelor of Applied Science in Biochemistry and Molecular Biology from Penn State University and a Master's in Biotechnology, Bioengineering, and Biomedical Engineering from the University of Pennsylvania.